Total Payments
$415,234
2024 Payments
$13,952
Companies
52
Transactions
816
Medicare Patients
8,156
Medicare Billing
$500,386
Payment Breakdown by Category
Other$292,388 (70.4%)
Consulting$36,790 (8.9%)
Royalty/License$29,768 (7.2%)
Food & Beverage$28,583 (6.9%)
Travel$27,516 (6.6%)
Education$188.69 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $292,246 | 100 | 70.4% |
| Consulting Fee | $36,790 | 30 | 8.9% |
| Royalty or License | $29,768 | 2 | 7.2% |
| Food and Beverage | $28,583 | 544 | 6.9% |
| Travel and Lodging | $27,516 | 133 | 6.6% |
| Education | $188.69 | 5 | 0.0% |
| Entertainment | $142.86 | 1 | 0.0% |
| Unspecified | $0 | 1 | 0.0% |
Payments by Type
General
$415,234
815 transactions
Ownership
$0
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $217,657 | 239 | $0 (2024) |
| Medtronic Vascular, Inc. | $37,655 | 35 | $0 (2020) |
| Abbott Laboratories | $33,642 | 111 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $29,132 | 53 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $26,323 | 38 | $0 (2019) |
| Gilead Sciences, Inc. | $23,467 | 37 | $0 (2018) |
| Merck Sharp & Dohme LLC | $21,365 | 19 | $0 (2024) |
| ARALEZ PHARMACEUTICALS US INC. | $14,217 | 22 | $0 (2018) |
| BOSTON SCIENTIFIC CORPORATION | $1,326 | 19 | $0 (2021) |
| Amgen Inc. | $1,171 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13,952 | 52 | Janssen Pharmaceuticals, Inc ($11,264) |
| 2023 | $39,332 | 55 | Merck Sharp & Dohme LLC ($20,669) |
| 2022 | $43,324 | 68 | Janssen Pharmaceuticals, Inc ($40,563) |
| 2021 | $29,237 | 49 | Janssen Pharmaceuticals, Inc ($27,301) |
| 2020 | $9,839 | 27 | Janssen Pharmaceuticals, Inc ($8,457) |
| 2019 | $116,953 | 167 | Janssen Pharmaceuticals, Inc ($69,243) |
| 2018 | $73,711 | 165 | Janssen Pharmaceuticals, Inc ($26,816) |
| 2017 | $88,887 | 233 | Gilead Sciences Inc ($22,946) |
All Payment Transactions
816 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $162.64 | General |
| Category: VTE | ||||||
| 12/17/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $24.71 | General |
| Category: Cardiology | ||||||
| 12/12/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $26.91 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: DIABETES | ||||||
| 12/03/2024 | CARDIVA MEDICAL, INC. | OPTOWIRE (Device) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: DEVICES | ||||||
| 11/20/2024 | Medtronic, Inc. | IN.PACT ADMIRAL (Device) | Food and Beverage | In-kind items and services | $62.60 | General |
| Category: Drug-Coated Balloons | ||||||
| 11/18/2024 | Abbott Laboratories | ENSITE PRECISION (Device) | Food and Beverage | In-kind items and services | $171.92 | General |
| Category: Electrophysiology | ||||||
| 11/15/2024 | Medtronic, Inc. | IN.PACT ADMIRAL (Device) | Food and Beverage | In-kind items and services | $11.37 | General |
| Category: Drug-Coated Balloons | ||||||
| 11/12/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Transcatheter Heart Valves | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $28.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/01/2024 | Abbott Laboratories | PERCLOSE PROSTYLE (Device) | Food and Beverage | In-kind items and services | $106.39 | General |
| Category: Vascular | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/02/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $119.70 | General |
| Category: Cardiology | ||||||
| 09/23/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Not Applicable | ||||||
| 09/16/2024 | Abbott Laboratories | TACTICATH ABLATION CATHETER, SENSOR ENABLED (Device) | Food and Beverage | In-kind items and services | $133.25 | General |
| Category: Electrophysiology | ||||||
| 09/14/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: Structural Heart | ||||||
| 08/27/2024 | CARDIVA MEDICAL, INC. | OPTOWIRE (Device) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: DEVICES | ||||||
| 08/21/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $152.80 | General |
| Category: Lithoplasty | ||||||
| 08/16/2024 | Abbott Laboratories | ESPRIT (Device) | Food and Beverage | In-kind items and services | $124.01 | General |
| Category: Vascular | ||||||
| 07/25/2024 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $26.97 | General |
| Category: Dermatology | ||||||
| 07/03/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Heart Failure | ||||||
| 06/13/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $36.38 | General |
| Category: Cardiology | ||||||
| 06/12/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $137.34 | General |
| Category: Structural Heart | ||||||
| 06/05/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $113.64 | General |
| Category: Transcatheter Heart Valves | ||||||
| 05/22/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $125.57 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,864 | 2,451 | $230,321 | $108,972 |
| 2022 | 21 | 1,965 | 2,622 | $278,089 | $129,855 |
| 2021 | 18 | 2,307 | 2,948 | $311,295 | $143,719 |
| 2020 | 15 | 2,020 | 2,643 | $281,809 | $117,841 |
Total Patients
8,156
Total Services
10,664
Medicare Billing
$500,386
Procedure Codes
96
All Medicare Procedures & Services
96 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 217 | 418 | $51,832 | $30,254 | 58.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 137 | 296 | $38,778 | $18,838 | 48.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 164 | 165 | $24,750 | $9,753 | 39.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 114 | 114 | $17,100 | $6,387 | 37.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 46 | 81 | $8,100 | $5,254 | 64.9% |
| 93264 | Remote monitoring of pulmonary artery pressure sensor, up to 30 days | Office | 2023 | 18 | 136 | $9,520 | $4,996 | 52.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 31 | 31 | $5,301 | $2,897 | 54.6% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 13 | 13 | $8,671 | $2,884 | 33.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 20 | 20 | $5,260 | $2,873 | 54.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 164 | 165 | $6,765 | $2,704 | 40.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 24 | 24 | $4,320 | $2,413 | 55.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $4,812 | $2,150 | 44.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 14 | 17 | $3,111 | $2,012 | 64.7% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 117 | 117 | $4,797 | $1,842 | 38.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 164 | 165 | $4,950 | $1,808 | 36.5% |
| 36200 | Insertion of tube into aorta | Facility | 2023 | 16 | 16 | $4,160 | $1,690 | 40.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 30 | 31 | $5,200 | $1,670 | 32.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 12 | $2,196 | $1,313 | 59.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 24 | 24 | $3,600 | $1,294 | 35.9% |
| 75630 | Review by radiologist of abdominal aorta and both leg arteries image | Facility | 2023 | 18 | 18 | $2,826 | $1,293 | 45.8% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 117 | 117 | $3,510 | $1,230 | 35.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 175 | 196 | $2,940 | $1,218 | 41.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 145 | 178 | $2,670 | $973.67 | 36.5% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 46 | 58 | $4,060 | $624.66 | 15.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 12 | 13 | $1,092 | $601.92 | 55.1% |
About Dr. Marcel Zughaib, M.D
Dr. Marcel Zughaib, M.D is a Interventional Cardiology healthcare provider based in Southfield, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922038488.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marcel Zughaib, M.D has received a total of $415,234 in payments from pharmaceutical and medical device companies, with $13,952 received in 2024. These payments were reported across 816 transactions from 52 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($292,246).
As a Medicare-enrolled provider, Zughaib has provided services to 8,156 Medicare beneficiaries, totaling 10,664 services with total Medicare billing of $500,386. Data is available for 4 years (2020–2023), covering 96 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Cardiovascular Disease
- Location Southfield, MI
- Active Since 07/03/2006
- Last Updated 01/13/2014
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1922038488
Products in Payments
- XARELTO (Drug) $217,583
- VenaSeal (Device) $29,768
- CardioMEMS HF System (Device) $28,612
- PRALUENT (Drug) $26,244
- PRALUENT ALIROCUMAB INJECTION (Biological) $24,386
- Ranexa (Drug) $23,391
- VERQUVO (Drug) $20,725
- ZONTIVITY (Drug) $14,217
- PRALUENT (Biological) $4,746
- HawkOne (Device) $4,496
- Resolute (Device) $2,720
- WATCHMAN (Device) $1,155
- ENTRESTO (Drug) $1,066
- Repatha (Biological) $1,009
- IN.PACT Admiral (Device) $783.69
- AMPLATZER AMULET (Device) $647.76
- Xeomin (Biological) $647.47
- MK-1242 (Drug) $640.88
- LifeVest (Device) $611.72
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $488.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.